Head and neck sarcoidosis, from wait and see to tumor necrosis factor alpha therapy: A pilot study
Head & Neck, 06/26/2012
Knopf A et al. – Most patients with head and neck sarcoidosis did not require systemic therapy. The authors suggest corticosteroid–pulse therapy for patients with severe head and neck manifestation. Adalimumab might be potent for nonresponder.